ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

721
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
•14 Jun 2021 20:08

KRX Plans to Launch a New Index Called 'KOSPI 200 Top 10'

According to the KRX, it plans to launch new indices which would include the top 10 stocks in KOSPI. The name of this index is expected to be...

Logo
416 Views
Share
•10 Apr 2021 16:14

NPS Raises Domestic Equity Allocations

NPS increased the strategic asset allocation (SAA) limit for domestic equities from the current 2% to 3%. As a result of this change, the sale of...

Logo
575 Views
Share
•05 Jul 2026 10:20

KRX Foreign Holding Weekly (Jul 3rd): Samsung Electronics, SK Hynix, SKSQUARE, SamsungElecMech

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, SK Hynix, SKSQUARE,...

Logo
121 Views
Share
•03 Feb 2021 20:02

PARTIAL END of Ban on Short Selling of Stocks in Korea

Korea Financial Services Commission (FSC) announced after the market close today that there will be a PARTIAL end of the ban on short selling of...

Logo
478 Views
Share
•07 Dec 2020 20:41

The Stocks to Own in Asia – Vol. 31

The Stocks to Own in Asia – Vol. 31. We highlight 14 stocks in Asia that look interesting to us based upon our FVMR Methodology.

Share
x